These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9340562)

  • 1. [AIDS; new developments. IV. Changes in primary medical care due to new possibilities of treating HIV-infected patients].
    Wigersma L
    Ned Tijdschr Geneeskd; 1997 May; 141(21):1051-4. PubMed ID: 9340562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral drug treatment for HIV/AIDS.
    Goldschmidt RH; Moy A
    Am Fam Physician; 1996 Aug; 54(2):574-80, 587-8. PubMed ID: 8701838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV protease inhibitors (new possibilities in the treatment of HIV infection and AIDS)].
    Bálint GS
    Orv Hetil; 1998 Jun; 139(24):1471-4. PubMed ID: 9658865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic impact of delaying or preventing AIDS in persons with HIV.
    Pinkerton SD; Holtgrave DR
    Am J Manag Care; 1999 Mar; 5(3):289-98. PubMed ID: 10351025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The picture of future therapy.
    Gazzard B
    Int J Clin Pract Suppl; 1999 Jun; 103():45-8. PubMed ID: 10622045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
    Cuzin L; Allavena C; Morlat P; Dellamonica P
    AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current clinical treatments of AIDS.
    Murphy EM; Jimenez HR; Smith SM
    Adv Pharmacol; 2008; 56():27-73. PubMed ID: 18086408
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary care and specialty care in the age of HAART.
    Soloway B
    AIDS Clin Care; 1997 May; 9(5):37-9. PubMed ID: 11364297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].
    Jambroes M; Weverling GJ; Reiss P; Danner SA; Jurriaans S; ten Veen JH; van der Ende ME; Schutten M; Schneider MM; Schuurman R; Mulder JW; Kroes AC; Lange JM; de Wolf F;
    Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1591-7. PubMed ID: 11534377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical issues regarding the use of antiretroviral therapy for HIV infection.
    Deeks SG
    West J Med; 1998 Feb; 168(2):133-9. PubMed ID: 9499754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New treatments for HIV].
    Garcia E
    Sidahora; 1996; ():48-50. PubMed ID: 11363630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystoid macular edema and cytomegalovirus retinitis in AIDS patients treated with antiretroviral triple therapy].
    Badelon I; Gohier P; Chaine G
    J Fr Ophtalmol; 1999 Dec; 22(10):1034-41. PubMed ID: 10617840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic aspects of HIV/AIDS infected patients and evaluation of therapeutic protocols].
    Reszketö Z; Szlávik J; Balogh J; Vincze Z
    Acta Pharm Hung; 2001 Dec; 71(4):428-32. PubMed ID: 12113183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antiretrovirals and new combinations.
    Havlir DV; Lange JM
    AIDS; 1998; 12 Suppl A():S165-74. PubMed ID: 9632999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
    Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
    Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV treatment options.
    Smith D
    AIDS Treat News; 1998 May; (No 294):4-5. PubMed ID: 11365404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of enhanced interferon alpha levels in sera of HIV-infected and AIDS patients receiving combined antiretroviral therapy.
    Piasecki E; Knysz B; Gasiorowski J; Gładysz A
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):37-44. PubMed ID: 11729827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.